The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

PharMerica Corp

NYSE: PMC
Last

(U.S.) $25.30

Today's change+0.25 +1.00%
Updated January 20 4:02 PM EST. Delayed by at least 15 minutes.
 

PharMerica Corp

NYSE: PMC
Last

(U.S.) $25.30

Today's change+0.25 +1.00%
Updated January 20 4:02 PM EST. Delayed by at least 15 minutes.

PharMerica Corp up (U.S.)$0.25

PharMerica Corp closed up Friday by (U.S.)$0.25 or 1.00% to (U.S.)$25.30. Over the last five days, shares have lost 3.44% and 17.05% over the last 52 weeks. This security has underperformed the S&P 500 by 39.21% during the last year.

Key company metrics

  • Open(U.S.) $25.00
  • Previous close(U.S.) $25.05
  • High(U.S.) $25.30
  • Low(U.S.) $24.95
  • Bid / Ask-- / --
  • YTD % change+0.60%
  • Volume158,966
  • Average volume (10-day)138,903
  • Average volume (1-month)192,177
  • Average volume (3-month)272,448
  • 52-week range(U.S.) $19.20 to (U.S.) $31.59
  • Beta1.10
  • Trailing P/E22.84×
  • P/E 1 year forward13.56×
  • Forward PEG2.80×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $1.11
Updated January 20 4:02 PM EST. Delayed by at least 15 minutes.
S&P TSX0.90%Sector:Non-Cyclical Consumer Goods & ServicesIndustry:Retail - Drugs
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2016Q2/2016Q1/2016Q4/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201609/30/2016Jun 30, 201606/30/2016Mar 31, 201603/31/2016Dec 31, 201512/31/2015
Revenue513520525521
Total other revenue--------
Total revenue513520525521
Gross profit79828287
Total cost of revenue434438443434
Total operating expense501512517501
Selling / general / administrative53565755
Research & development--------
Depreciation / amortization8888
Interest expense (income), net operating--------
Unusual expense (income)51093
Other operating expenses, total--------
Operating income128820
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax94519
Income after tax73420
Income tax, total221-1
Net income73420
Total adjustments to net income--------
Net income before extra. items73420
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items73420
Inc. avail. to common incl. extra. items73420
Diluted net income73420
Dilution adjustment--------
Diluted weighted average shares31313131
Diluted EPS excluding extraordinary itemsvalue per share0.230.080.130.66
Dividends per sharevalue per share0.000.000.00--
Diluted normalized EPSvalue per share0.370.280.380.73